(Q38205387)

31 August 2017

title

Amniotic fluid-derived mesenchymal stem cells: characteristics and therapeutic applications (English)

1 reference

31 August 2017

main subject

mesenchymal stem cell

1 reference

Jun Zhou

1

1 reference

31 August 2017

Dejun Wang

2

1 reference

31 August 2017

Tian Liang

3

1 reference

31 August 2017

Qiuyan Guo

4

1 reference

31 August 2017

Guangmei Zhang

5

1 reference

31 August 2017

publication date

18 April 2014

1 reference

Archives of Gynecology and Obstetrics

31 August 2017

published in

1 reference

31 August 2017

volume

290

1 reference

31 August 2017

issue

2

1 reference

31 August 2017

page(s)

223-231

1 reference

https://scigraph.springernature.com/pub.10.1007/s00404-014-3231-7

31 August 2017

exact match

0 references

cites work

Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

The immunosuppressive properties of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Human ES cells and a blastocyst from one embryo: exciting science but conflicting ethics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Isolation of amniotic stem cell lines with potential for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Isolation, characterization, and in vitro differentiation of ovine amniotic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Oct-4: gatekeeper in the beginnings of mammalian development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Comparison of human amniotic fluid-derived and umbilical cord Wharton's Jelly-derived mesenchymal stromal cells: Characterization and myocardial differentiation capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Sarcoma derived from cultured mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Derivation of Embryonic Stem-Cell Lines from Human Blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Lack of telomerase activity in human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Mesenchymal stem cells as therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Fetal tracheal reconstruction with cartilaginous grafts engineered from mesenchymal amniocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Engineered mesenchymal stem cells for cartilage repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Calcification after myocardial infarction is independent of amniotic fluid stem cell injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

CD117(+) amniotic fluid stem cells: state of the art and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Why do so many cancer patients fail to respond to interferon therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-014-3231-7

10.1007/S00404-014-3231-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1016583613

0 references

1 reference